Cargando…
Correlation of High-Risk Soft Tissue Sarcoma Biomarker Expression Patterns with Outcome following Neoadjuvant Chemoradiation
BACKGROUND: Sarcoma mortality remains high despite adjuvant chemotherapy. Biomarker predictors of treatment response and outcome could improve treatment selection. METHODS: Tissue microarrays (TMAs) were created using pre- and posttreatment tumor from two prospective trials (MGH pilot and RTOG 9514)...
Autores principales: | Kane, John M., Magliocco, Anthony, Zhang, Qiang, Wang, Dian, Klimowicz, Alex, Harris, Jonathan, Simko, Jeff, DeLaney, Thomas, Kraybill, William, Kirsch, David G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851029/ https://www.ncbi.nlm.nih.gov/pubmed/29681762 http://dx.doi.org/10.1155/2018/8310950 |
Ejemplares similares
-
Neoadjuvant Chemoradiation Herapy for Soft Tissue Sarcomas of the Extremities
por: Aguiar, Samuel, et al.
Publicado: (2009) -
Thromboembolic Events Associated with Thalidomide and Multimodality Therapy for Soft Tissue Sarcomas: Results of RTOG 0330
por: Kane, J. M., et al.
Publicado: (2012) -
Neoadjuvant Chemoradiation Compared With Neoadjuvant Radiation Alone in the Management of High-Grade Soft Tissue Extremity Sarcomas
por: Hazell, Sarah Z., et al.
Publicado: (2019) -
Neoadjuvant chemoradiation compared to neoadjuvant radiation alone and surgery alone for Stage II and III soft tissue sarcoma of the extremities
por: Curtis, Kelly K, et al.
Publicado: (2011) -
The Treatment and Outcome of Patients With Soft Tissue Sarcomas and Synchronous Metastases
por: Kane, John M., et al.
Publicado: (2002)